References
- Alshehri OM, Montague S, Watson S, Carter P, Sarker N, Manne BK, Miller JL, Herr AB, Pollitt AY, O’Callaghan CA et al. Activation of glycoprotein vi (gpvi) and c-type lectin-like receptor-2 (clec-2) underlies platelet activation by diesel exhaust particles and other charged/hydrophobic ligands. Biochem J. 2015;468(3):459–473. https://doi.org/10.1042/BJ20150192
- Zia F, Kendall M, Watson SP, Mendes PM. Platelet aggregation induced by polystyrene and platinum nanoparticles is dependent on surface area. RSC Adv. 2018;8(66):37789–37794. https://doi.org/10.1039/C8RA07315E
- Damaskinaki F-N, Moran LA, Garcia A, Kellam B, Watson SP. Overcoming challenges in developing small molecule inhibitors for gpvi and clec-2. Platelets. 2021:1–9. https://doi.org/10.1080/09537104.2020.1863939
- Bayda S, Adeel M, Tuccinardi T, Cordani M, Rizzolio F. The history of nanoscience and nanotechnology: from chemical-physical applications to nanomedicine. Molecules. 2019;25(1):112. https://doi.org/10.3390/molecules25010112
- Singh P, Pandit S, Mokkapati VRSS, Garg A, Ravikumar V, Mijakovic I. Gold nanoparticles in diagnostics and therapeutics for human cancer. Int J Mol Sci. 2018;19(7):1979. https://doi.org/10.3390/ijms19071979
- Jeyaraj M, Gurunathan S, Qasim M, Kang M-H, Kim J-H. A comprehensive review on the synthesis, characterization, and biomedical application of platinum nanoparticles. Nanomaterials. 2019;9(12):1719. https://doi.org/10.3390/nano9121719
- Burdușel AC, Gherasim O, Grumezescu AM, Mogoantă L, Ficai A, Andronescu E. Biomedical applications of silver nanoparticles: an up-to-date overview. Nanomaterials. 2018;8(9):681. https://doi.org/10.3390/nano8090681
- Pedone D, Moglianetti M, De Luca E, Bardi G, Pompa PP. Platinum nanoparticles in nanobiomedicine. Chem Soc Rev. 2017;46(16)4951–4975.
- Ajnai G, Chiu A, Kan T, Cheng -C-C, Tsai T-H, Chang J. Trends of gold nanoparticle-based drug delivery system in cancer therapy. J Exp Med. 2014;6(6)172–178.
- Chen Y-H, Tsai C-Y, Huang P-Y, Chang M-Y, Cheng P-C, Chou C-H, Chen D-H, Wang C-R, Shiau A-L, Wu C-L. Methotrexate conjugated to gold nanoparticles inhibits tumor growth in a syngeneic lung tumor model. Mol Pharm. 2007;4(5):713–722. https://doi.org/10.1021/mp060132k
- Liao Y-J, Shiang Y-C, Huang -C-C, Chang H-T. Molecularly imprinted aptamers of gold nanoparticles for the enzymatic inhibition and detection of thrombin. Langmuir. 2012;28(24):8944–8951. https://doi.org/10.1021/la204651t
- Shabanova EM, Drozdov AS, Fakhardo AF, Dudanov IP, Kovalchuk MS, Vinogradov VV. Thrombin@fe(3)o(4) nanoparticles for use as a hemostatic agent in internal bleeding. Sci Rep. 2018;8(1):233. https://doi.org/10.1038/s41598-017-18665-4
- Neuwelt A, Sidhu N, Hu CA, Mlady G, Eberhardt SC, Sillerud LO. Iron-based superparamagnetic nanoparticle contrast agents for mri of infection and inflammation. AJR Am J Roentgenol. 2015;204(3):302–313. https://doi.org/10.2214/AJR.14.12733
- Dadfar SM, Roemhild K, Drude NI, von Stillfried S, Knüchel R, Kiessling F, Lammers T. Iron oxide nanoparticles: diagnostic, therapeutic and theranostic applications. Adv Drug Deliv Rev. 2019;138:302–325.
- Hrapovic S, Liu Y, Male KB, Luong JHT. Electrochemical biosensing platforms using platinum nanoparticles and carbon nanotubes. Anal Chem. 2004;76(4):1083–1088. https://doi.org/10.1021/ac035143t
- Claussen JC, Kim SS, Haque AU, Artiles MS, Porterfield DM, Fisher TS. Electrochemical glucose biosensor of platinum nanospheres connected by carbon nanotubes. J Diabetes Sci Technol. 2010;4(2):312–319. https://doi.org/10.1177/193229681000400211
- Chen D, Zhao C, Ye J, Li Q, Liu X, Su M, Jiang H, Amatore C, Selke M, Wang X. In situ biosynthesis of fluorescent platinum nanoclusters: toward self-bioimaging-guided cancer theranostics. ACS Appl Mater Interfaces. 2015;7(32):18163–18169. https://doi.org/10.1021/acsami.5b05805
- Clark A, Zhu A, Sun K, Petty HR. Cerium oxide and platinum nanoparticles protect cells from oxidant-mediated apoptosis. J Nanopart Res. 2011;13(10):5547–5555. https://doi.org/10.1007/s11051-011-0544-3
- Han M, Gao X, Su JZ, Nie S. Quantum-dot-tagged microbeads for multiplexed optical coding of biomolecules. Nat Biotechnol. 2001;19(7):631–635. https://doi.org/10.1038/90228
- Alshehri R, Ilyas AM, Hasan A, Arnaout A, Ahmed F, Memic A. Carbon nanotubes in biomedical applications: factors, mechanisms, and remedies of toxicity. J Med Chem. 2016;59(18):8149–8167. https://doi.org/10.1021/acs.jmedchem.5b01770
- Lunova M, Prokhorov A, Jirsa M, Hof M, Olżyńska A, Jurkiewicz P, Š K, Lunov O, Dejneka A. Nanoparticle core stability and surface functionalization drive the mtor signaling pathway in hepatocellular cell lines. Sci Rep. 2017;7(1):16049. https://doi.org/10.1038/s41598-017-16447-6
- Caminade A-M, Turrin C-O. Dendrimers for drug delivery. J Mater Chem B. 2014;2(26):4055–4066. https://doi.org/10.1039/C4TB00171K
- Cheng J, Meziani MJ, Sun Y-P, Cheng SH. Poly(ethylene glycol)-conjugated multi-walled carbon nanotubes as an efficient drug carrier for overcoming multidrug resistance. Toxicol Appl Pharmacol. 2011;250(2):184–193. https://doi.org/10.1016/j.taap.2010.10.012
- Villa CH, Dao T, Ahearn I, Fehrenbacher N, Casey E, Rey DA, Korontsvit T, Zakhaleva V, Batt CA, Philips MR et al. Single-walled carbon nanotubes deliver peptide antigen into dendritic cells and enhance igg responses to tumor-associated antigens. ACS Nano. 2011;5(7):5300–5311. https://doi.org/10.1021/nn200182x
- Navarro-Tovar G, Palestino G, Rosales-Mendoza S. An overview on the role of silica-based materials in vaccine development. Expert Rev Vaccines. 2016;15(11):1449–1462. https://doi.org/10.1080/14760584.2016.1188009
- Niculescu V-C. Mesoporous silica nanoparticles for bio-applications. Front Mater. 2020;7:36. https://doi.org/10.3389/fmats.2020.00036
- Madaan K, Kumar S, Poonia N, Lather V, Pandita D. Dendrimers in drug delivery and targeting: drug-dendrimer interactions and toxicity issues. J Pharm Bioallied Sci. 2014;6(3):139–150. https://doi.org/10.4103/0975-7406.130965
- Fox LJ, Richardson RM, Briscoe WH. Pamam dendrimer - cell membrane interactions. Adv Colloid Interface Sci. 2018;257:1–18. https://doi.org/10.1016/j.cis.2018.06.005
- Dobrovolskaia MA, Patri AK, Simak J, Hall JB, Semberova J, De Paoli Lacerda SH, McNeil SE. Nanoparticle size and surface charge determine effects of pamam dendrimers on human platelets in vitro. Mol Pharm. 2012;9(3):382–393. https://doi.org/10.1021/mp200463e
- Miller MR, Newby DE. Air pollution and cardiovascular disease: car sick. Cardiovasc Res. 2019;116(2)279–294.
- Ohlwein S, Kappeler R, Kutlar Joss M, Künzli N, Hoffmann B. Health effects of ultrafine particles: a systematic literature review update of epidemiological evidence. Int J Public Health. 2019;64(4):547–559. https://doi.org/10.1007/s00038-019-01202-7
- Franchini M, Guida A, Tufano A, Coppola A. Air pollution, vascular disease and thrombosis: linking clinical data and pathogenic mechanisms. J Thromb Haemost. 2012;10(12):2438–2451. https://doi.org/10.1111/jth.12006
- Alarabi AB, Karim ZA, Ramirez JEM, Hernandez KR, Lozano PA, Rivera JO, Alshbool FZ, Khasawneh FT. Short-term exposure to waterpipe/hookah smoke triggers a hyperactive platelet activation state and increases the risk of thrombogenesis. Arterioscler Thromb Vasc Biol. 2020;40(2):335–349. https://doi.org/10.1161/ATVBAHA.119.313435
- Mills NL, Törnqvist H, Robinson SD, Gonzalez M, Darnley K, MacNee W, Boon NA, Donaldson K, Blomberg A, Sandstrom T et al. Diesel exhaust inhalation causes vascular dysfunction and impaired endogenous fibrinolysis. Circulation. 2005;112(25):3930–3936. https://doi.org/10.1161/CIRCULATIONAHA.105.588962
- Langrish JP, Lundbäck M, Mills NL, Johnston NR, Webb DJ, Sandström T, Blomberg A, Newby DE. Contribution of endothelin 1 to the vascular effects of diesel exhaust inhalation in humans. Hypertension. 2009;54(4):910–915. https://doi.org/10.1161/HYPERTENSIONAHA.109.135947
- Miller MR, Raftis JB, Langrish JP, McLean SG, Samutrtai P, Connell SP, Wilson S, Vesey AT, Fokkens PHB, Boere AJF et al. Inhaled nanoparticles accumulate at sites of vascular disease. ACS Nano. 2017;11(5):4542–4552. https://doi.org/10.1021/acsnano.6b08551
- Oberdörster G, Sharp Z, Atudorei V, Elder A, Gelein R, Lunts A, Kreyling W, Cox C. Extrapulmonary translocation of ultrafine carbon particles following whole-body inhalation exposure of rats. J Toxicol Environ Health A. 2002;65(20):1531–1543. https://doi.org/10.1080/00984100290071658
- Solomon A, Smyth E, Mitha N, Pitchford S, Vydyanath A, Luther PK, Thorley AJ, Tetley TD, Emerson M. Induction of platelet aggregation after a direct physical interaction with diesel exhaust particles. J Thromb Haemost. 2013;11(2):325–334. https://doi.org/10.1111/jth.12087
- Lei J, Li Z, Huang X, Li X, Zhang G, Kan H, Chen R, Zhang Y. The acute effect of diesel exhaust particles and different fractions exposure on blood coagulation function in mice. Int J Environ Health Res. 2021;18(8).
- Tabor CM, Shaw CA, Robertson S, Miller MR, Duffin R, Donaldson K, Newby DE, Hadoke PW. Platelet activation independent of pulmonary inflammation contributes to diesel exhaust particulate-induced promotion of arterial thrombosis. Part Fibre Toxicol. 2016;13(6). https://doi.org/10.1186/s12989-016-0116-x.
- Deb S, Patra HK, Lahiri P, Dasgupta AK, Chakrabarti K, Chaudhuri U. Multistability in platelets and their response to gold nanoparticles. Nanomedicine. 2011;7(4):376–384. https://doi.org/10.1016/j.nano.2011.01.007
- Dobrovolskaia MA, Patri AK, Zheng J, Clogston JD, Ayub N, Aggarwal P, Neun BW, Hall JB, McNeil SE. Interaction of colloidal gold nanoparticles with human blood: effects on particle size and analysis of plasma protein binding profiles. Nanomed Nanotechnol Biol Med. 2009;5(2):106–117. https://doi.org/10.1016/j.nano.2008.08.001
- Aseychev AV, Azizova OA, Beckman EM, Dudnik LB, Sergienko VI. Effect of gold nanoparticles coated with plasma components on adp-induced platelet aggregation. Bull Exp Biol Med. 2013;155(5):685–688. https://doi.org/10.1007/s10517-013-2226-x
- Ajdari N, Vyas C, Bogan SL, Lwaleed BA, Cousins BG. Gold nanoparticle interactions in human blood: a model evaluation. Nanomed Nanotechnol Biol Med. 2017;13(4):1531–1542. https://doi.org/10.1016/j.nano.2017.01.019
- Huang H, Lai W, Cui M, Liang L, Lin Y, Fang Q, Liu Y, Xie L. An evaluation of blood compatibility of silver nanoparticles. Sci Rep. 2016;6(1):25518. https://doi.org/10.1038/srep25518
- Jun E-A, Lim K-M, Kim K, Bae O-N, Noh J-Y, Chung K-H, Chung J-H. Silver nanoparticles enhance thrombus formation through increased platelet aggregation and procoagulant activity. Nanotoxicology. 2011;5(2):157–167. https://doi.org/10.3109/17435390.2010.506250
- Shrivastava S, Bera T, Singh SK, Singh G, Ramachandrarao P, Dash D. Characterization of antiplatelet properties of silver nanoparticles. ACS Nano. 2009;3(6):1357–1364. https://doi.org/10.1021/nn900277t
- Laloy J, Minet V, Alpan L, Mullier F, Beken S, Toussaint O, Lucas S, Dogné J-M. Impact of silver nanoparticles on haemolysis, platelet function and coagulation. Nanobiomedicine. 2014;1(4):4. https://doi.org/10.5772/59346
- Deb S, Raja SO, Dasgupta AK, Sarkar R, Chattopadhyay AP, Chaudhuri U, Guha P, Sardar P. Surface tunability of nanoparticles in modulating platelet functions. Blood Cells Mol Dis. 2012;48(1):36–44. https://doi.org/10.1016/j.bcmd.2011.09.011
- Liu T, Bai R, Zhou H, Wang R, Liu J, Zhao Y, Chen C. The effect of size and surface ligands of iron oxide nanoparticles on blood compatibility. RSC Adv. 2020;10(13):7559–7569. https://doi.org/10.1039/C9RA10969B
- Nemmar A, Hoylaerts MF, Hoet PH, Dinsdale D, Smith T, Xu H, Vermylen J, Nemery B. Ultrafine particles affect experimental thrombosis in an in vivo hamster model. Am J Crit Care Med. 2002;166(7):998–1004. https://doi.org/10.1164/rccm.200110-026OC
- Smyth E, Solomon A, Vydyanath A, Luther PK, Pitchford S, Tetley TD, Emerson M. Induction and enhancement of platelet aggregation in vitro and in vivo by model polystyrene nanoparticles. Nanotoxicology. 2015;9(3):356–364. https://doi.org/10.3109/17435390.2014.933902
- Radomski A, Jurasz P, Alonso-Escolano D, Drews M, Morandi M, Malinski T, Radomski MW. Nanoparticle-induced platelet aggregation and vascular thrombosis. Br J Pharmacol. 2005;146(6):882–893. https://doi.org/10.1038/sj.bjp.0706386
- Semberova J, De Paoli Lacerda SH, Simakova O, Holada K, Gelderman MP, Simak J. Carbon nanotubes activate blood platelets by inducing extracellular ca2+ influx sensitive to calcium entry inhibitors. Nano Lett. 2009;9(9):3312–3317. https://doi.org/10.1021/nl901603k
- Guidetti GF, Consonni A, Cipolla L, Mustarelli P, Balduini C, Torti M. Nanoparticles induce platelet activation in vitro through stimulation of canonical signalling pathways. Nanomed Nanotechnol Biol Med. 2012;8(8):1329–1336. https://doi.org/10.1016/j.nano.2012.04.001
- Ritz S, Schöttler S, Kotman N, Baier G, Musyanovych A, Kuharev J, Landfester K, Schild H, Jahn O, Tenzer S et al. Protein corona of nanoparticles: distinct proteins regulate the cellular uptake. Biomacromolecules. 2015;16(4):1311–1321. https://doi.org/10.1021/acs.biomac.5b00108
- Cedervall T, Lynch I, Lindman S, Berggård T, Thulin E, Nilsson H, Dawson KA, Linse S. Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles. Proc Natl Acad Sci USA. 2007;104(7):2050–2055. https://doi.org/10.1073/pnas.0608582104
- Guildford AL, Poletti T, Osbourne LH, Di Cerbo A, Gatti AM, Santin M. Nanoparticles of a different source induce different patterns of activation in key biochemical and cellular components of the host response. J R Soc Interface. 2009;6(41):1213–1221. https://doi.org/10.1098/rsif.2009.0021
- Kardeby C, Fälker K, Haining EJ, Criel M, Lindkvist M, Barroso R, Påhlsson P, Ljungberg LU, Tengdelius M, Rainger GE et al. Synthetic glycopolymers and natural fucoidans cause human platelet aggregation via pear1 and gpibα. Blood Adv. 2019;3(3):275–287. https://doi.org/10.1182/bloodadvances.2018024950
- Thanh NTK, Maclean N, Mahiddine S. Mechanisms of nucleation and growth of nanoparticles in solution. Chem Rev. 2014;114(15):7610–7630. https://doi.org/10.1021/cr400544s
- Polte J. Fundamental growth principles of colloidal metal nanoparticles – a new perspective. Cryst Eng Comm. 2015;17(36):6809–6830. https://doi.org/10.1039/C5CE01014D
- Mout R, Moyano DF, Rana S, Rotello VM. Surface functionalization of nanoparticles for nanomedicine. Chem Soc Rev. 2012;41(7):2539–2544. https://doi.org/10.1039/c2cs15294k
- Conde J, Dias JT, Grazú V, Moros M, Baptista PV. de la Fuente JM. Revisiting 30 years of biofunctionalization and surface chemistry of inorganic nanoparticles for nanomedicine. Front Chem. 2014;2(48).
- Eklund SE, Cliffel DE. Synthesis and catalytic properties of soluble platinum nanoparticles protected by a thiol monolayer. Langmuir. 2004;20(14):6012–6018. https://doi.org/10.1021/la049787n
- Heinz H, Pramanik C, Heinz O, Ding Y, RK M, Marchon D, RJ F, Estrela-Lopis I, Llop J, Moya S, et al. Nanoparticle decoration with surfactants: molecular interactions, assembly, and applications. Surf Sci Rep. 2017;72(1):1–58.
- Durrant TN, Van Den Bosch MT, Hers I. Integrin α(iib)β(3) outside-in signaling. Blood. 2017;130(14):1607–1619. https://doi.org/10.1182/blood-2017-03-773614
- Rayes J, Watson SP, Nieswandt B. Functional significance of the platelet immune receptors gpvi and clec-2. J Clin Invest. 2019;129(1):12–23. https://doi.org/10.1172/JCI122955
- Mammadova-Bach E, Ollivier V, Loyau S, Schaff M, Dumont B, Favier R, Freyburger G, Latger-Cannard V, Nieswandt B, Gachet C et al. Platelet glycoprotein vi binds to polymerized fibrin and promotes thrombin generation. Blood. 2015;126(5):683–691. https://doi.org/10.1182/blood-2015-02-629717
- Alshehri OM, Hughes CE, Montague S, Watson SK, Frampton J, Bender M, Watson SP. Fibrin activates gpvi in human and mouse platelets. Blood. 2015;126(13):1601–1608. https://doi.org/10.1182/blood-2015-04-641654
- Mangin PH, Onselaer MB, Receveur N, Le Lay N, Hardy AT, Wilson C, Sanchez X, Loyau S, Dupuis A, Babar AK et al. Immobilized fibrinogen activates human platelets through glycoprotein vi. Haematologica. 2018;103(5):898–907. https://doi.org/10.3324/haematol.2017.182972
- Mammadova-Bach E, Gil-Pulido J, Sarukhanyan E, Burkard P, Shityakov S, Schonhart C, Stegner D, Remer K, Nurden P, Nurden AT et al. Platelet glycoprotein vi promotes metastasis through interaction with cancer cell-derived galectin-3. Blood. 2020;135(14):1146–1160. https://doi.org/10.1182/blood.2019002649
- Gardiner EE. Proteolytic processing of platelet receptors. RPTH. 2018;2(2):240–250. https://doi.org/10.1002/rth2.12096
- Krueger I, Gremer L, Mangels L, Klier M, Jurk K, Willbold D, Bock HH, Elvers M. Reelin amplifies glycoprotein vi activation and alphaiib beta3 integrin outside-in signaling via plc gamma 2 and rho gtpases. Arterioscler Thromb Vasc Biol. 2020;40(10):2391–2403. https://doi.org/10.1161/ATVBAHA.120.314902
- Donner L, Toska LM, Krüger I, Gröniger S, Barroso R, Burleigh A, Mezzano D, Pfeiler S, Kelm M, Gerdes N et al. The collagen receptor glycoprotein vi promotes platelet-mediated aggregation of β-amyloid. Sci Signal. 2020;13(643):eaba9872. https://doi.org/10.1126/scisignal.aba9872
- Montague SJ, Hicks SM, Lee CS-M, Coupland LA, Parish CR, Lee WM, Andrews RK, Gardiner EE. Fibrin exposure triggers αiibβ3-independent platelet aggregate formation, adam10 activity and glycoprotein vi shedding in a charge-dependent manner. J Thromb Haemost. 2020;18(6):1447–1458. https://doi.org/10.1111/jth.14797
- Chanzu H, Lykins J, Wigna-Kumar S, Joshi S, Pokrovskaya I, Storrie B, Pejler G, Wood JP, Whiteheart SW. Platelet α-granule cargo packaging and release are affected by the luminal proteoglycan, serglycin. J Thromb Haemost. 2021. https://doi.org/10.1111/jth.15243
- Flierl U, Nero TL, Lim B, Arthur JF, Yao Y, Jung SM, Gitz E, Pollitt AY, Zaldivia MTK, Jandrot-Perrus M et al. Phosphorothioate backbone modifications of nucleotide-based drugs are potent platelet activators. J Exp Med. 2015;212(2):129–137. https://doi.org/10.1084/jem.20140391
- Nagy M, Perrella G, Dalby A, Becerra MF, Garcia Quintanilla L, Pike JA, Morgan NV, Gardiner EE, Heemskerk JWM, Azócar L et al. Flow studies on human gpvi-deficient blood under coagulating and noncoagulating conditions. Blood Adv. 2020;4(13):2953–2961. https://doi.org/10.1182/bloodadvances.2020001761
- Matus V, Valenzuela G, Sáez CG, Hidalgo P, Lagos M, Aranda E, Panes O, Pereira J, Pillois X, Nurden AT et al. An adenine insertion in exon 6 of human GP6 generates a truncated protein associated with a bleeding disorder in four Chilean families. J Thromb Haemost. 2013;11(9):1751–1759. https://doi.org/10.1111/jth.12334
- Andrews RK, Suzuki-Inoue K, Shen Y, Tulasne D, Watson SP, Berndt MC. Interaction of calmodulin with the cytoplasmic domain of platelet glycoprotein vi. Blood. 2002;99(11):4219–4221. https://doi.org/10.1182/blood-2001-11-0008
- Moroi M, Jung SM. Platelet glycoprotein vi: its structure and function. Thromb Res. 2004;114(4):221–233. https://doi.org/10.1016/j.thromres.2004.06.046
- Slater A, Di Y, Clark JC, Jooss NJ, Martin EM, Alenazy F, Thomas MR, Ariëns RAS, Herr AB, Poulter NS et al. Structural characterization of a novel GPVI-nanobody complex reveals a biologically active domain-swapped GPVI dimer. Blood. 2021;137(24):3443–3453. https://doi.org/10.1182/blood.2020009440
- Horii K, Kahn ML, Herr AB. Structural basis for platelet collagen responses by the immune-type receptor glycoprotein vi. Blood. 2006;108(3):936–942. https://doi.org/10.1182/blood-2006-01-010215
- O’Connor MN, Smethurst PA, Farndale RW, Ouwehand WH. Gain- and loss-of-function mutants confirm the importance of apical residues to the primary interaction of human glycoprotein vi with collagen. J Thromb Haemost. 2006;4(4):869–873. https://doi.org/10.1111/j.1538-7836.2005.01764.x
- Martin E, Zuidscherwoude M, Moran L, Di Y, Garcia A, Watson S. The structure of CLEC-2: mechanisms of dimerization and higher-order clustering. Platelets. 2021:1–11. https://doi.org/10.1080/09537104.2021.1906407
- Manne BK, Getz TM, Hughes CE, Alshehri O, Dangelmaier C, Naik UP, Watson SP, Kunapuli SP. Fucoidan is a novel platelet agonist for the c-type lectin-like receptor 2 (clec-2). J Bio Chem 2013;288(11):7717–7726. https://doi.org/10.1074/jbc.M112.424473
- Nagae M, Morita-Matsumoto K, Kato M, Kaneko Mika M, Kato Y, Yamaguchi Y. A Platform of C-type Lectin-like Receptor CLEC-2 for Binding O -Glycosylated Podoplanin and Nonglycosylated Rhodocytin. Structure. 2014;22(12):1711–1721. https://doi.org/10.1016/j.str.2014.09.009
- Dunster JL, Unsworth AJ, Bye AP, Haining EJ, Sowa MA, Di Y, Sage T, Pallini C, Pike JA, Hardy AT et al. Interspecies differences in protein expression do not impact the spatiotemporal regulation of glycoprotein vi mediated activation. J Thromb Haemost. 2020;18(2):485–496. https://doi.org/10.1111/jth.14673
- Wight TN. A role for proteoglycans in vascular disease. Matrix Biol. 2018;71-72:396–420.
- Bentzon JF, Otsuka F, Virmani R, Falk E. Mechanisms of plaque formation and rupture. Circ Res. 2014;114(12):1852–1866. https://doi.org/10.1161/CIRCRESAHA.114.302721
- Badimon L, Vilahur G. Thrombosis formation on atherosclerotic lesions and plaque rupture. Journal of Internal Medicine. 2014;276(6):618–632. https://doi.org/10.1111/joim.12296
- Penz S, Reininger AJ, Brandl R, Goyal P, Rabie T, Bernlochner I, Rother E, Goetz C, Engelmann B, Smethurst PA et al. Human atheromatous plaques stimulate thrombus formation by activating platelet glycoprotein vi. FASEB J. 2005;19(8):898–909. https://doi.org/10.1096/fj.04-2748com
- Schulz C, Penz S, Hoffmann C, Langer H, Gillitzer A, Schneider S, Brandl R, Seidl S, Massberg S, Pichler B et al. Platelet gpvi binds to collagenous structures in the core region of human atheromatous plaque and is critical for atheroprogression in vivo. Basic Res Cardiol. 2008;103(4):356–367. https://doi.org/10.1007/s00395-008-0722-3
- Susen S, Rauch A, Van Belle E, Vincentelli A, Lenting PJ. Circulatory support devices: fundamental aspects and clinical management of bleeding and thrombosis. J Thromb Haemost. 2015;13(10):1757–1767. https://doi.org/10.1111/jth.13120
- Muthiah K, Connor D, Ly K, Gardiner EE, Andrews RK, Qiao J, Rutgers D, Robson D, Low J, Jarvis S et al. Longitudinal changes in hemostatic parameters and reduced pulsatility contribute to non-surgical bleeding in patients with centrifugal continuous-flow left ventricular assist devices. J Heart Lung Transplant. 2016;35(6):743–751. https://doi.org/10.1016/j.healun.2015.12.024
- Chen Z, Mondal NK, Zheng S, Koenig SC, Slaughter MS, Griffith BP, Wu ZJ. High shear induces platelet dysfunction leading to enhanced thrombotic propensity and diminished hemostatic capacity. Platelets. 2019;30(1):112–119. https://doi.org/10.1080/09537104.2017.1384542
- Gitz E, Pollitt AY, Gitz-Francois JJ, Alshehri O, Mori J, Montague S, Nash GB, Douglas MR, Gardiner EE, Andrews RK et al. Clec-2 expression is maintained on activated platelets and on platelet microparticles. Blood. 2014;124(14):2262–2270. https://doi.org/10.1182/blood-2014-05-572818
- Matzinger P. Tolerance, danger, and the extended family. Annu Rev of Immunol. 1994;12:991–1045(1). https://doi.org/10.1146/annurev.iy.12.040194.005015
- Mogensen TH. Pathogen recognition and inflammatory signaling in innate immune defenses. Clin Microbiol Rev. 2009;22(2)240–273.
- Dib PRB, Quirino‐Teixeira AC, Merij LB, Pinheiro MBM, Rozini SV, Andrade FB, Hottz ED. Innate immune receptors in platelets and platelet-leukocyte interactions.J Leukoc Biol. 2020;108(4):1157–1182. https://doi.org/10.1002/JLB.4MR0620-701R
- Fuchs TA, Brill A, Duerschmied D, Schatzberg D, Monestier M, Myers DD, Wrobleski SK, Wakefield TW, Hartwig JH, Wagner DD. Extracellular DNA traps promote thrombosis. Proc Natl Acad Sci USA. 2010;107(36):15880–15885. https://doi.org/10.1073/pnas.1005743107
- Zhang Q, Raoof M, Chen Y, Sumi Y, Sursal T, Junger W, Brohi K, Itagaki K, Hauser CJ. Circulating mitochondrial damps cause inflammatory responses to injury. Nature. 2010;464(7285):104–107. https://doi.org/10.1038/nature08780
- Semeraro F, Ammollo CT, Morrissey JH, Dale GL, Friese P, Esmon NL, Esmon CT. Extracellular histones promote thrombin generation through platelet-dependent mechanisms: involvement of platelet tlr2 and tlr4. Blood. 2011;118(7):1952–1961. https://doi.org/10.1182/blood-2011-03-343061
- Vogel S, Bodenstein R, Chen Q, Feil S, Feil R, Rheinlaender J, Schäffer TE, Bohn E, Frick J-S, Borst O et al. Platelet-derived hmgb1 is a critical mediator of thrombosis. J Clin Invest. 2015;125(12):4638–4654. https://doi.org/10.1172/JCI81660
- Garraud O, Hamzeh-Cognasse H, Pozzetto B, Cavaillon J-M, Cognasse F. Bench-to-bedside review: platelets and active immune functions - new clues for immunopathology? Crit Care. 2013;17(4):236. https://doi.org/10.1186/cc12716
- Cognasse F. The inflammatory role of platelets via their tlrs and siglec receptors. Front Immunol. 2015;6:83. https://doi.org/10.3389/fimmu.2015.00083
- Kawasaki T, Kawai T. Toll-like receptor signaling pathways. Front Immunol. 2014;5:461. https://doi.org/10.3389/fimmu.2014.00461
- Montrucchio G, Bosco O, Del Sorbo L, Fascio Pecetto P, Lupia E, Goffi A, Omedè P, Emanuelli G, Camussi G. Mechanisms of the priming effect of low doses of lipopoly-saccharides on leukocyte-dependent platelet aggregation in whole blood. Thromb Haemost. 2003;90(5):872–881. https://doi.org/10.1160/TH03-02-0085
- Andonegui G, Kerfoot SM, McNagny K, Ebbert KVJ, Patel KD, Kubes P. Platelets express functional toll-like receptor-4. Blood. 2005;106(7):2417–2423. https://doi.org/10.1182/blood-2005-03-0916
- Ward JR, Bingle L, Judge HM, Brown SB, Storey RF, Whyte MK, Dower SK, Buttle DJ, Sabroe I. Agonists of toll-like receptor (tlr)2 and tlr4 are unable to modulate platelet activation by adenosine diphosphate and platelet activating factor. Thromb Haemost. 2005;94(4)831–838.
- de Stoppelaar SF, Claushuis TAM, Schaap MCL, Hou B, van der Poll T, Nieuwland R, Van ‘T Veer C. Toll-like receptor signalling is not involved in platelet response to streptococcus pneumoniae in vitro or in vivo. PLOS ONE. 2016;11(6):e0156977. https://doi.org/10.1371/journal.pone.0156977
- Ahrens I, Chen YC, Topcic D, Bode M, Haenel D, Hagemeyer CE, Seeba H, Duerschmied D, Bassler N, Jandeleit-Dahm KA et al. Hmgb1 binds to activated platelets via the receptor for advanced glycation end products and is present in platelet rich human coronary artery thrombi. Thromb Haemost. 2015;114(5):994–1003. https://doi.org/10.1160/TH14-12-1073
- Chaipan C, Soilleux EJ, Simpson P, Hofmann H, Gramberg T, Marzi A, Geier M, Stewart EA, Eisemann J, Steinkasserer A et al. Dc-sign and clec-2 mediate human immunodeficiency virus type 1 capture by platelets. J Virol. 2006;80(18):8951–8960. https://doi.org/10.1128/JVI.00136-06
- Sung P-S, Huang T-F, Hsieh S-L. Extracellular vesicles from clec2-activated platelets enhance dengue virus-induced lethality via clec5a/tlr2. Nat Commun. 2019;10(1):2402. https://doi.org/10.1038/s41467-019-10360-4
- Bourne JH, Colicchia M, Di Y, Martin E, Slater A, Roumenina LT, Dimitrov JD, Watson SP, Rayes J. Heme induces human and mouse platelet activation through c-type-lectin-like receptor-2. Haematologica. 2021;106(2):626–629. https://doi.org/10.3324/haematol.2020.246488
- Maas C, Renné T. Coagulation factor xii in thrombosis and inflammation. Blood. 2018;131(17):1903–1909. https://doi.org/10.1182/blood-2017-04-569111
- Grover Steven P, Mackman N. Intrinsic pathway of coagulation and thrombosis. Arterioscler Thromb Vasc Biol. 2019;39(3):331–338. https://doi.org/10.1161/ATVBAHA.118.312130
- Verhoef JJF, Barendrecht AD, Nickel KF, Dijkxhoorn K, Kenne E, Labberton L, OJT M, Schiffelers R, Heijnen HF, Hendrickx AP et al. Polyphosphate nanoparticles on the platelet surface trigger contact system activation. Blood. 2017;129(12):1707–1717. https://doi.org/10.1182/blood-2016-08-734988
- Didiasova M, Wujak L, Schaefer L, Wygrecka M. Factor xii in coagulation, inflammation and beyond. Cell Signal. 2018;51:257–265. https://doi.org/10.1016/j.cellsig.2018.08.006